Ascension Asset Management’s Edwards Lifesciences EW Stock Holding History

Ascension Asset Management’s Portfolio EW Stock Details EW Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q2	$1.54M	Sell	16,650 -1,275	-7%	-$113K	0.8%	44
2024 Q1	$1.71M	Buy	+17,925	New	+$1.51M	0.92%	41
2023 Q2	$1.68M	Buy	+17,800	New	+$1.55M	1.03%	37
2022 Q4	$1.34M	Hold	17,950	–	–	0.97%	45
2022 Q3	$1.48M	Hold	17,950	–	–	1.16%	38
2022 Q2	$1.71M	Buy	+17,950	New	+$1.86M	1.26%	32
2021 Q4	$2.38M	Sell	18,330 -105	-0.6%	-$12.2K	1.41%	26
2021 Q3	$2.09M	Hold	18,435	–	–	1.36%	27
2021 Q2	$1.91M	Sell	18,435 -75	-0.4%	-$7.07K	1.25%	36
2021 Q1	$1.55M	Buy	+18,510	New	+$1.56M	1.08%	40
2020 Q4	–	Sell	-19,125	Closed	-$1.53M	–	55
2020 Q3	$1.53M	Buy	+19,125	New	+$1.49M	1.22%	36
2020 Q1	$1.21M	Buy	57,690 +44,490	+337%	+$3.21M	1.26%	36
2019 Q4	$1.03M	Hold	13,200	–	–	0.89%	53
2019 Q3	$968K	Hold	13,200	–	–	0.89%	50
2019 Q2	$813K	Hold	13,200	–	–	0.72%	57
2019 Q1	$842K	Hold	13,200	–	–	0.76%	59
2018 Q4	$674K	Hold	13,200	–	–	0.68%	58
2018 Q3	$766K	Hold	13,200	–	–	0.67%	58
2018 Q2	$641K	Hold	13,200	–	–	0.59%	61
2018 Q1	$614K	Hold	13,200	–	–	0.56%	65
2017 Q4	$496K	Buy	+13,200	New	+$484K	0.45%	65

Other funds holding EW

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Brown Advisory Baltimore, Maryland $60.9B AUM 15.24% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

Ascension Asset Management's EW Position: Q2 2024 in Review

Ascension Asset Management reduced its Edwards Lifesciences (EW) stake by 7.1% in Q2 2024, selling an estimated $113K and leaving 16,650 shares worth $1.54M. The position accounts for 0.8% of the portfolio, ranked #44.

Ascension Asset Management first reported a position in EW in Q4 2017 and has held it in 21 quarters since. The position peaked at $2.38M in Q4 2021. 1,295 funds tracked by Wall St. Rank hold EW as of Q2 2024.

Ascension Asset Management held 16,650 shares of Edwards Lifesciences worth $1.54M as of Q2 2024.
Ascension Asset Management sold 1,275 Edwards Lifesciences shares in Q2 2024, an estimated $113K.
Edwards Lifesciences made up 0.8% of Ascension Asset Management's portfolio in Q2 2024, its #44 holding.
Ascension Asset Management first reported a position in Edwards Lifesciences in Q4 2017 and has held it in 21 quarters since.
Ascension Asset Management's Edwards Lifesciences position peaked at $2.38M in Q4 2021.
1,295 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q2 2024.

Based on Ascension Asset Management's 13F filing for Q2 2024, filed 16 Aug 2024.